Brief: Humacyte Terminates Revenue Interest Purchase Agreement
15/12/2025 16:21
Dec 15 (Reuters) - Humacyte Inc HUMA.O: HUMACYTE INC - TERMINATES REVENUE INTEREST PURCHASE AGREEMENT DATED MAY 12, 2023 - SEC FILING HUMACYTE INC - UNDER AGREEMENT, TO PAY $38 MILLION AND ISSUE 5.7 MILLION SHARES - SEC FILING Source text: [ID:n0001104659-25-120915] Further company coverage: HUMA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary